These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 31071550
1. The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbS/βthal), correlate with markers of hemolysis, iron burden, coagulation, endothelial dysfunction and pulmonary hypertension. Larissi K, Politou M, Margeli A, Poziopoulos C, Flevari P, Terpos E, Papassotiriou I, Voskaridou E. Blood Cells Mol Dis; 2019 Jul; 77():137-141. PubMed ID: 31071550 [Abstract] [Full Text] [Related]
2. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications. Tantawy AA, Adly AA, Ismail EA, Darwish YW, Ali Zedan M. Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856 [Abstract] [Full Text] [Related]
3. Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density. Voskaridou E, Ntanasis-Stathopoulos I, Christoulas D, Dimopoulou M, Komninaka V, Repa K, Papatheodorou A, Terpos E. Ann Hematol; 2019 Jul; 98(7):1583-1592. PubMed ID: 31041514 [Abstract] [Full Text] [Related]
5. The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expression. Allard P, Tagliaferri L, Weru V, Cario H, Lobitz S, Grosse R, Bleeke M, Oevermann L, Hakimeh D, Jarisch A, Kopp-Schneider A, Kulozik AE, Kunz JB, German Sickle Cell Disease Study Group, Lassay L. Eur J Haematol; 2024 Oct; 113(4):501-509. PubMed ID: 38946051 [Abstract] [Full Text] [Related]
6. Growth differentiation factor-15 in children and adolescents with thalassemia intermedia: Relation to subclinical atherosclerosis and pulmonary vasculopathy. Tantawy AA, Adly AA, Ismail EA, Youssef OI, Ali ME. Blood Cells Mol Dis; 2015 Aug; 55(2):144-50. PubMed ID: 26142330 [Abstract] [Full Text] [Related]
17. Transforming growth factor 15 increased in severe aplastic anemia patients. Shao Y, Wang H, Liu C, Cao Q, Fu R, Wang H, Wang T, Qi W, Shao Z. Hematology; 2017 Oct; 22(9):548-553. PubMed ID: 28385068 [Abstract] [Full Text] [Related]
19. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications. Tantawy AA, Adly AA, Ismail EA, Habeeb NM, Farouk A. Platelets; 2013 Oct; 24(8):605-14. PubMed ID: 23249216 [Abstract] [Full Text] [Related]
20. Genetic Regulation of Redox Balance in β-Thalassemia Trait. Terán MM, Mónaco ME, Lazarte SS, Haro C, Ledesma Achem E, Asensio NA, Issé BA. Hemoglobin; 2020 Mar; 44(2):122-127. PubMed ID: 32448013 [Abstract] [Full Text] [Related] Page: [Next] [New Search]